Iovance Biotherapeutics (NASDAQ:IOVA) Given New $15.00 Price Target at Truist Financial
Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) had its price objective trimmed by Truist Financial from $25.00 to $15.00 in a research note issued to investors on Monday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Other equities analysts have also issued reports about the stock. Chardan Capital reduced their […]
Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) had its price objective trimmed by Truist Financial from $25.00 to $15.00 in a research note issued to investors on Monday morning,Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. Other equities analysts have also issued reports about the stock. Chardan Capital reduced their […]
